 Karen Moulton
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 6 | 2023 | 409 | 0.980 |
Why?
| | Vascular Remodeling | 6 | 2022 | 209 | 0.940 |
Why?
| | Coronary Vessels | 2 | 2018 | 246 | 0.940 |
Why?
| | Heart-Assist Devices | 4 | 2022 | 568 | 0.930 |
Why?
| | Myocytes, Smooth Muscle | 7 | 2026 | 270 | 0.930 |
Why?
| | PTEN Phosphohydrolase | 4 | 2020 | 165 | 0.880 |
Why?
| | Fibrosis | 8 | 2026 | 559 | 0.790 |
Why?
| | Neovascularization, Pathologic | 4 | 2011 | 286 | 0.790 |
Why?
| | Plaque, Atherosclerotic | 3 | 2023 | 61 | 0.700 |
Why?
| | Muscle, Smooth, Vascular | 7 | 2026 | 449 | 0.560 |
Why?
| | Collagen Type XVIII | 2 | 2010 | 5 | 0.550 |
Why?
| | Myofibroblasts | 4 | 2026 | 148 | 0.420 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2026 | 82 | 0.390 |
Why?
| | Aortic Diseases | 2 | 2021 | 125 | 0.350 |
Why?
| | Matrix Metalloproteinases | 1 | 2011 | 95 | 0.330 |
Why?
| | Heart Failure | 3 | 2021 | 2326 | 0.330 |
Why?
| | Basement Membrane | 1 | 2010 | 32 | 0.330 |
Why?
| | Lipoprotein Lipase | 1 | 2010 | 56 | 0.320 |
Why?
| | Hypertriglyceridemia | 1 | 2010 | 45 | 0.320 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2011 | 199 | 0.310 |
Why?
| | Angiotensin II | 3 | 2026 | 101 | 0.290 |
Why?
| | Hypercholesterolemia | 2 | 2023 | 95 | 0.280 |
Why?
| | Mice | 21 | 2026 | 18329 | 0.280 |
Why?
| | Receptors, LDL | 5 | 2023 | 53 | 0.280 |
Why?
| | Stem Cells | 4 | 2026 | 628 | 0.270 |
Why?
| | Diabetic Nephropathies | 1 | 2011 | 322 | 0.260 |
Why?
| | Apolipoproteins E | 4 | 2009 | 93 | 0.260 |
Why?
| | Vasa Vasorum | 2 | 2004 | 36 | 0.250 |
Why?
| | Mice, Inbred C57BL | 11 | 2026 | 5983 | 0.240 |
Why?
| | Sugar Acids | 1 | 2026 | 4 | 0.240 |
Why?
| | Arteriosclerosis | 2 | 2003 | 83 | 0.220 |
Why?
| | Mice, Knockout | 9 | 2026 | 3124 | 0.210 |
Why?
| | Cell Differentiation | 7 | 2026 | 2046 | 0.210 |
Why?
| | Animals | 22 | 2026 | 38030 | 0.210 |
Why?
| | Capillary Permeability | 1 | 2004 | 132 | 0.200 |
Why?
| | Gene Expression | 2 | 2022 | 1476 | 0.200 |
Why?
| | Spinocerebellar Ataxias | 1 | 2022 | 6 | 0.180 |
Why?
| | Vascular System Injuries | 1 | 2023 | 81 | 0.180 |
Why?
| | Genes, X-Linked | 1 | 2022 | 21 | 0.180 |
Why?
| | X Chromosome Inactivation | 1 | 2022 | 25 | 0.180 |
Why?
| | Aortic Valve Insufficiency | 1 | 2022 | 43 | 0.180 |
Why?
| | Aortic Valve | 2 | 2022 | 364 | 0.180 |
Why?
| | Assisted Circulation | 1 | 2021 | 26 | 0.170 |
Why?
| | Myocardium | 2 | 2026 | 934 | 0.170 |
Why?
| | Gene Expression Regulation | 5 | 2022 | 2597 | 0.170 |
Why?
| | Lipoproteins | 2 | 2014 | 166 | 0.170 |
Why?
| | Macrophages | 5 | 2007 | 1507 | 0.160 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 16 | 0.160 |
Why?
| | Receptors, Lipoprotein | 3 | 1995 | 15 | 0.160 |
Why?
| | Actins | 2 | 2022 | 425 | 0.150 |
Why?
| | Peptide Fragments | 2 | 2003 | 693 | 0.150 |
Why?
| | Receptors, Immunologic | 3 | 1995 | 208 | 0.140 |
Why?
| | Tunica Intima | 1 | 1999 | 78 | 0.140 |
Why?
| | Sesquiterpenes | 1 | 1999 | 52 | 0.140 |
Why?
| | Cells, Cultured | 8 | 2026 | 4148 | 0.140 |
Why?
| | Immunohistochemistry | 4 | 2022 | 1716 | 0.140 |
Why?
| | Disease Models, Animal | 5 | 2026 | 4560 | 0.140 |
Why?
| | Antibodies, Monoclonal | 1 | 2026 | 1505 | 0.140 |
Why?
| | Mice, Knockout, ApoE | 1 | 2018 | 11 | 0.140 |
Why?
| | High-Throughput Screening Assays | 1 | 2020 | 176 | 0.140 |
Why?
| | Aorta, Thoracic | 2 | 2007 | 286 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 1994 | 54 | 0.130 |
Why?
| | Hyperplasia | 1 | 2018 | 177 | 0.130 |
Why?
| | Extracellular Matrix | 1 | 2021 | 562 | 0.130 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 956 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2019 | 252 | 0.120 |
Why?
| | Collagen | 1 | 1999 | 457 | 0.120 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 285 | 0.120 |
Why?
| | Promoter Regions, Genetic | 4 | 2020 | 1246 | 0.120 |
Why?
| | Serum Response Factor | 1 | 2016 | 33 | 0.120 |
Why?
| | Male | 13 | 2026 | 72842 | 0.120 |
Why?
| | Heart | 2 | 2018 | 626 | 0.110 |
Why?
| | Ventricular Function, Left | 1 | 2018 | 542 | 0.110 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2011 | 3922 | 0.100 |
Why?
| | Macrophages, Peritoneal | 1 | 1994 | 89 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 2 | 1994 | 624 | 0.100 |
Why?
| | Transcription Factors | 3 | 2023 | 1734 | 0.100 |
Why?
| | Membrane Proteins | 3 | 1995 | 1164 | 0.100 |
Why?
| | Lymphatic Vessels | 1 | 2014 | 63 | 0.100 |
Why?
| | Mice, Transgenic | 5 | 2020 | 2188 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2004 | 552 | 0.090 |
Why?
| | Humans | 19 | 2026 | 145474 | 0.090 |
Why?
| | Endostatins | 2 | 2004 | 10 | 0.090 |
Why?
| | Genes | 1 | 1992 | 227 | 0.090 |
Why?
| | Female | 9 | 2023 | 78844 | 0.090 |
Why?
| | Cell Adhesion Molecules | 1 | 1992 | 181 | 0.080 |
Why?
| | Rats | 3 | 2019 | 5584 | 0.080 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2010 | 23 | 0.080 |
Why?
| | Encephalocele | 1 | 2010 | 12 | 0.080 |
Why?
| | Retinal Degeneration | 1 | 2010 | 40 | 0.080 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 156 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 2 | 2016 | 2524 | 0.080 |
Why?
| | DNA-Binding Proteins | 2 | 1994 | 1480 | 0.080 |
Why?
| | MAP Kinase Kinase Kinase 3 | 1 | 2009 | 4 | 0.080 |
Why?
| | Retinal Detachment | 1 | 2010 | 73 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 267 | 0.070 |
Why?
| | In Vitro Techniques | 3 | 2004 | 1048 | 0.070 |
Why?
| | Simvastatin | 1 | 2009 | 59 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 977 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 848 | 0.070 |
Why?
| | Triglycerides | 1 | 2010 | 520 | 0.070 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2009 | 167 | 0.070 |
Why?
| | Middle Aged | 3 | 2021 | 36215 | 0.070 |
Why?
| | Profilins | 1 | 2007 | 3 | 0.070 |
Why?
| | Aged | 2 | 2018 | 26153 | 0.070 |
Why?
| | Cholesterol | 2 | 2023 | 408 | 0.060 |
Why?
| | Receptors, Scavenger | 4 | 1995 | 22 | 0.060 |
Why?
| | Vasculitis | 1 | 2007 | 69 | 0.060 |
Why?
| | Antigens, Ly | 1 | 2026 | 45 | 0.060 |
Why?
| | Campylobacter jejuni | 1 | 2026 | 16 | 0.060 |
Why?
| | Acinetobacter baumannii | 1 | 2026 | 26 | 0.060 |
Why?
| | Biomarkers | 2 | 2022 | 4295 | 0.060 |
Why?
| | Helicobacter pylori | 1 | 2026 | 44 | 0.060 |
Why?
| | Glycopeptides | 1 | 2026 | 44 | 0.060 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 443 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 141 | 0.050 |
Why?
| | Diet, Atherogenic | 1 | 2004 | 6 | 0.050 |
Why?
| | Cholesterol, Dietary | 1 | 2004 | 15 | 0.050 |
Why?
| | Adult | 2 | 2018 | 40777 | 0.050 |
Why?
| | E-Selectin | 1 | 2004 | 61 | 0.050 |
Why?
| | Organ Culture Techniques | 1 | 2004 | 154 | 0.050 |
Why?
| | Phagocytosis | 1 | 2026 | 296 | 0.050 |
Why?
| | Gene Dosage | 1 | 2004 | 145 | 0.050 |
Why?
| | Corn Oil | 1 | 2023 | 5 | 0.050 |
Why?
| | Angiostatins | 1 | 2003 | 3 | 0.050 |
Why?
| | Proprotein Convertase 9 | 1 | 2023 | 87 | 0.050 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2003 | 78 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2003 | 62 | 0.050 |
Why?
| | Plasminogen | 1 | 2003 | 27 | 0.050 |
Why?
| | Blotting, Western | 2 | 2019 | 1179 | 0.050 |
Why?
| | Lymphokines | 1 | 2003 | 128 | 0.050 |
Why?
| | Muscle, Smooth | 1 | 2023 | 153 | 0.050 |
Why?
| | Chemokine CCL2 | 1 | 2003 | 112 | 0.050 |
Why?
| | Angiogenesis Inhibitors | 1 | 2004 | 238 | 0.050 |
Why?
| | Neointima | 1 | 2022 | 18 | 0.050 |
Why?
| | Feedback | 1 | 2003 | 180 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2023 | 177 | 0.040 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.040 |
Why?
| | ADAMTS4 Protein | 1 | 2021 | 16 | 0.040 |
Why?
| | Long Term Adverse Effects | 1 | 2021 | 13 | 0.040 |
Why?
| | Cell Nucleus | 3 | 1994 | 588 | 0.040 |
Why?
| | DNA Helicases | 1 | 2023 | 136 | 0.040 |
Why?
| | Base Sequence | 3 | 1994 | 2170 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2003 | 376 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2004 | 529 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 1994 | 2883 | 0.040 |
Why?
| | Scavenger Receptors, Class B | 3 | 1995 | 14 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 85 | 0.040 |
Why?
| | Monocytes | 1 | 2003 | 539 | 0.040 |
Why?
| | Endothelial Cells | 2 | 2022 | 874 | 0.040 |
Why?
| | Mutation | 1 | 2010 | 4075 | 0.040 |
Why?
| | Skin | 1 | 2004 | 753 | 0.040 |
Why?
| | Cyclohexanes | 1 | 1999 | 22 | 0.040 |
Why?
| | Swine | 1 | 2022 | 825 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.040 |
Why?
| | Azacitidine | 1 | 2020 | 157 | 0.040 |
Why?
| | Chromatin | 1 | 2023 | 553 | 0.040 |
Why?
| | Arteries | 1 | 2020 | 261 | 0.040 |
Why?
| | Aortic Valve Stenosis | 1 | 2022 | 256 | 0.040 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 211 | 0.040 |
Why?
| | Cell Count | 1 | 1999 | 319 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 679 | 0.030 |
Why?
| | Homeostasis | 1 | 2022 | 642 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 1995 | 92 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2023 | 740 | 0.030 |
Why?
| | Phenotype | 1 | 2026 | 3155 | 0.030 |
Why?
| | Cell Division | 1 | 1999 | 756 | 0.030 |
Why?
| | DNA | 2 | 1994 | 1435 | 0.030 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1994 | 149 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1162 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2105 | 0.030 |
Why?
| | Foam Cells | 1 | 1995 | 17 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 1038 | 0.030 |
Why?
| | Gene Targeting | 1 | 1995 | 81 | 0.030 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 1994 | 10 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 14218 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor Receptor-3 | 1 | 2014 | 7 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 1994 | 56 | 0.030 |
Why?
| | Luciferases | 1 | 1994 | 153 | 0.030 |
Why?
| | Apolipoproteins B | 1 | 2014 | 47 | 0.030 |
Why?
| | Signal Transduction | 3 | 2022 | 5216 | 0.030 |
Why?
| | Substrate Specificity | 1 | 1994 | 387 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1994 | 376 | 0.020 |
Why?
| | RNA | 1 | 2019 | 910 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 1994 | 191 | 0.020 |
Why?
| | HeLa Cells | 1 | 1994 | 632 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1994 | 886 | 0.020 |
Why?
| | Transfection | 1 | 1994 | 926 | 0.020 |
Why?
| | Sequence Alignment | 1 | 1992 | 362 | 0.020 |
Why?
| | Adolescent | 1 | 2011 | 22529 | 0.020 |
Why?
| | Inflammation | 1 | 2003 | 2878 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1992 | 538 | 0.020 |
Why?
| | Trans-Activators | 1 | 1994 | 396 | 0.020 |
Why?
| | Atrioventricular Node | 1 | 1991 | 15 | 0.020 |
Why?
| | Radio Waves | 1 | 1991 | 28 | 0.020 |
Why?
| | Child | 1 | 2011 | 22707 | 0.020 |
Why?
| | Electrodes | 1 | 1991 | 111 | 0.020 |
Why?
| | Repressor Proteins | 1 | 1994 | 429 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2009 | 56 | 0.020 |
Why?
| | Renin-Angiotensin System | 1 | 2009 | 80 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 707 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2009 | 131 | 0.020 |
Why?
| | Cell Line | 1 | 1994 | 2823 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 365 | 0.020 |
Why?
| | Benzamides | 1 | 2009 | 226 | 0.020 |
Why?
| | Time Factors | 1 | 1999 | 7123 | 0.020 |
Why?
| | RNA, Messenger | 2 | 1994 | 2803 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 798 | 0.020 |
Why?
| | CD36 Antigens | 1 | 2007 | 32 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 42 | 0.020 |
Why?
| | Cardiac Catheterization | 1 | 1991 | 558 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2007 | 162 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2007 | 119 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2007 | 203 | 0.020 |
Why?
| | Heterozygote | 1 | 2007 | 313 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 1992 | 1454 | 0.010 |
Why?
| | Cardiac Surgical Procedures | 1 | 1991 | 610 | 0.010 |
Why?
| | HL-60 Cells | 1 | 2004 | 30 | 0.010 |
Why?
| | Transduction, Genetic | 1 | 2004 | 132 | 0.010 |
Why?
| | Cornea | 1 | 2004 | 154 | 0.010 |
Why?
| | Neovascularization, Physiologic | 1 | 2004 | 192 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 451 | 0.010 |
Why?
| | Gene Deletion | 1 | 2004 | 391 | 0.010 |
Why?
| | Leukocytes | 1 | 2004 | 296 | 0.010 |
Why?
| | Blood Pressure | 1 | 2009 | 1779 | 0.010 |
Why?
| | Aorta | 1 | 2004 | 440 | 0.010 |
Why?
| | Cell Movement | 1 | 2004 | 959 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 1997 | 0.010 |
Why?
| | Cytokines | 1 | 2004 | 2067 | 0.010 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1994 | 4 | 0.010 |
Why?
| | Genes, jun | 1 | 1994 | 9 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 1994 | 216 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1994 | 1368 | 0.010 |
Why?
| | Postoperative Period | 1 | 1991 | 351 | 0.000 |
Why?
| | Equipment Design | 1 | 1991 | 525 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1991 | 5423 | 0.000 |
Why?
|
|
Moulton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|